Back and Forth on Lab-Developed Tests | GenomeWeb

As the US Food and Drug Administration beefs up its oversight of lab-developed tests, some test developers are pushing back, the Wall Street Journal reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

To Regulate or Not?

Checking It Out

Issues Uncovered

Then Again, No

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.